LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis
出版年份 2019 全文链接
标题
LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis
作者
关键词
-
出版物
Human Cell
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-12
DOI
10.1007/s13577-019-00281-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2
- (2019) Dongyi Zhu et al. PATHOLOGY RESEARCH AND PRACTICE
- FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma
- (2019) Zhenwei He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Silencing of long noncoding RNA RP11‐476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA‐138‐5p‐dependent inhibition of LRRK2
- (2019) Yinlong Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL
- (2019) Jian Yan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- STAT1-mediated upregulation of lncRNA LINC00174 functions a ceRNA for miR-1910-3p to facilitate colorectal carcinoma progression through regulation of TAZ
- (2018) Ying Shen et al. GENE
- Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network
- (2018) Jie Ding et al. ONCOGENE
- MiR-30c impedes glioblastoma cell proliferation and migration by targeting SOX9
- (2018) Shihui Liu et al. ONCOLOGY RESEARCH
- LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway
- (2018) Chao Fu et al. Neurotherapeutics
- SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
- (2018) Xiaodong Yuan et al. BRITISH JOURNAL OF CANCER
- MiR‐34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin‐based chemotherapy
- (2018) Songshu Xiao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1
- (2017) Yungui Zheng et al. HUMAN PATHOLOGY
- lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b
- (2017) Bingzhou Cui et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expression Predicts Poor Prognosis
- (2017) Taku Higashihara et al. PANCREAS
- SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance
- (2017) Zhen Wang et al. Oncotarget
- Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis
- (2017) Jie Zhu et al. Oncotarget
- MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin
- (2017) Yuanyuan Qin et al. Theranostics
- MicroRNA-105 targets SOX9 and inhibits human glioma cell progression
- (2016) Xiyao Liu et al. FEBS LETTERS
- miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells
- (2016) Rong Yang et al. Molecular Cancer
- CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis
- (2016) Jian Zheng et al. MOLECULAR THERAPY
- The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer
- (2016) Lian Zhao et al. Oncotarget
- MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM
- (2016) Nina Stojcheva et al. Oncotarget
- MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9
- (2016) Nan Liu et al. Oncotarget
- Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9
- (2016) Jing Wang et al. Oncotarget
- miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1
- (2016) She Tian et al. Oncotarget
- SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling
- (2015) Hongwei Liu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124
- (2014) Yi Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SOX9: a stem cell transcriptional regulator of secreted niche signaling factors
- (2014) M. Kadaja et al. GENES & DEVELOPMENT
- Suppression of tumorigenicity by MicroRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme
- (2013) Shuwei Qiu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells
- (2013) S. B. Rani et al. NEURO-ONCOLOGY
- Oncogenic role of SOX9 expression in human malignant glioma
- (2012) Liang Wang et al. MEDICAL ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study
- (2009) Michael T. Milano et al. JOURNAL OF NEURO-ONCOLOGY
- SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms
- (2008) Valérie P.I. Vidal et al. JOURNAL OF CUTANEOUS PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now